HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary Tags: Visual edit Mobile edit Mobile web edit |
||
| Line 555: | Line 555: | ||
|Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | |Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | ||
|Complete | |Complete | ||
| | |||
| | |||
|- | |||
|RESOLVE 4th edition AML-Related NON-WHO entities content | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| Line 656: | Line 672: | ||
|Myeloid/lymphoid neoplasm with JAK2 rearrangement | |Myeloid/lymphoid neoplasm with JAK2 rearrangement | ||
|Disease | |Disease | ||
| | |Resolve Non-WHO entities | ||
| | | | ||
| | | | ||